The Seba library treats Medium in 5 passages, across 1 author (including McPheeters, Melissa).
the frequency of chills was assessed within each stimulus modality, to see if specific stimuli were particularly effective at eliciting chills
Bannister treats medium as the decisive variable determining the frequency and intensity of embodied aesthetic response, demonstrating that different expressive channels — image, text, video, music — are not interchangeable conveyors of psychological effect.
thesis
Withdrawals due to AEs 16; 5,480 Medium to high; RCTs Inconsistent Direct Imprecise RR, 1.16 (0.86 to 1.56) Low
McPheeters employs ‘medium’ as a standardized risk-of-bias rating that calibrates the evidentiary weight assigned to trial outcomes, functioning as a methodological intermediary between high confidence and low confidence designations.
, Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings: Systematic Review, 2023supporting
CI = confidence interval; Med = medium; n/N = sample size.
The systematic use of ‘Med’ as an abbreviated risk-of-bias category throughout the forest plot apparatus underscores ‘medium’ as a formal methodological classifier regulating the strength-of-evidence grades assigned to pharmacological comparisons.
, Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings: Systematic Review, 2023supporting
Return to any drinking 2; 939 Medium; RCTs Consistent Direct Imprecise RR, 0.96 (0.90 to 1.03) Low (no benefit)
A ‘Medium’ risk-of-bias designation on injectable naltrexone trials constrains the resulting strength-of-evidence grade to ‘Low,’ illustrating how the intermediate methodological rating functions as a ceiling on clinical inference.
, Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings: Systematic Review, 2023supporting
All offered 4 to 6 sessions of manualized compliance therapy Uptake/attendance NR Low … Group psychoeducation and social support Medium
Trial-level risk-of-bias ratings of ‘Medium’ attached to co-intervention conditions indicate that the adequacy of behavioral support components introduces intermediate confounding into pharmacotherapy outcome measurement.
, Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings: Systematic Review, 2023aside